ARCHIVES

Broder Emerges As National Leader In ASCO Talk, Calls For Faster Reporting Of Clinical

This article is from The Cancer Letter archive.

Vol. 15 No. 22 | June 2, 1989

Download PDF Visit The Full Archive

Related Articles

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

August 12, 2011

IMRT Less Toxic Than 3D-CRT In Localized Prostate Cancer

October 28, 2011

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

April 29, 2011

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

NCI Drops Breast Screening Guidelines, Issues “Summary Of Scientific Fact”

December 10, 1993

North General, MSK, Form Cancer Prevention Center.

June 30, 2000